CSF2 and graft versus host disease: A total of nine studies investigated the effects of several genes, including, IL-6 [93], GM-CSF [40, 94], and IFN-γ [200–202] KO/KD on reducing the rates of CRS, GVHD, neurotoxicity, and immunotoxicity of CAR T cells.